<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="journal" id="cas14841-cit-1001">
   <string-name>
    <surname>Takahashi</surname>
    <given-names>S</given-names>
   </string-name>, 
   <string-name>
    <surname>Sakamoto</surname>
    <given-names>Y</given-names>
   </string-name>, 
   <string-name>
    <surname>Denda</surname>
    <given-names>T</given-names>
   </string-name>, et al. 
   <article-title>Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer</article-title>. 
   <source xml:lang="en">Cancer Sci</source>. 
   <year>2021</year>;
   <volume>112</volume>:
   <fpage>1567</fpage>–
   <lpage>1578</lpage>. 
   <pub-id pub-id-type="doi">10.1111/cas.14841</pub-id>
  </mixed-citation>
 </p>
</notes>
